Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Drs. Julia Grapsa, Mohammad Kassar, Edoardo Zancanaro, and Hooman Bakhshi.
Commentary by Dr. Julia Grapsa
Raúl Córdoba, MD, PhD, discusses cardiotoxicities of treatments for hematological malignancies, the importance of geriatric hematology, and his views on the STOP-CA trial. Moderated by Sarah Waliany, MD, MS.
Carmen Bergom, MD, PhD, Alicia Morgans, MD, MPH, and June-Wha Rhee, MD discuss their experiences as women with careers in cardio-oncology, the importance of mentorship and sponsorship, rewards and challenges of building research careers, striking a balance with personal and family lives, negotiation strategies to address pay disparities, and institutional policies needed to advance the careers of women. Moderated by Sarah Waliany, MD, MS.
Erin Aakhus, MD, MSHP, Dipti Gupta, MD, MPH and Eric Yang, MD, FACC share their perspectives as fellowship Program Directors or Associate Program Directors on the process of applying for fellowship in cardiology, hematology/oncology, or cardio-oncology and how applicants can stand out as applicants. Moderated by Sarah Waliany, MD, MS.
Commentary by Social Media Editor Eiran Gorodeski
Commentary by Dr. Candice Silversides and Dr. Michael Honigberg
Commentary by Dr. Candice Silversides and Dr. Jaideep Patel
Commentary by Dr. Candice Silversides and Dr. Animesh Tandon
Commentary by Drs. Sadeer Al-Kindi, Anju Bhardwaj and Garima Sharma
Commentary by Drs. Sadeer Al-Kindi and Kazem Rahimi
Commentary by Drs. Pratik Doshi, John Tanaka and Jena Pizula discussing their insights and takeaways from the conference.
Commentary by Dr. Emile Daoud
Commentary by Dr. Emile Daoud
Commentary by Dr. Jonathan Piccini
Bonnie Ky, MD, MSCE, FACC and Megan Mulholland, MSc, the 2022 JACC: CardioOncology Young Author Achievement Award winner, discuss science and training in the field, career goals and plans, and her original research manuscript on immune therapy and atherosclerosis now online in JACC: CardioOncology.
Bonnie Ky, MD, MSCE, FACC, Ronald M. Witteles, MD, Marielle Scherrer-Crosbie, MD, PhD, and W. Greg Hundley, MD discuss the topic of statin cardioprotection, the STOP-CA trial presented at ACC.23, the PREVENT study published in NEJM Evidence, and the key takeaways of these two studies. Future directions and goals for the field are also discussed.
Ronald M. Witteles, MD and Sharmila Dorbala, MD, MPH discuss key takeaways from the ACC.23 session on Cardiac Amyloidosis in Real-World Clinical Practice
Commentary by Dr. Julia Grapsa
Commentary by Dr. Sean Pinney
Commentary by Dr. Paul Heidenreich